Representation of a leading global independent loss adjuster on its merger with a major player based in the UK.
Representation of the Nomad on the listing on AIM of MoneySwap plc, a specialist foreign exchange service provider in Asia with a market capitalisation of £20m.
Representation of an investment bank on secondary financing by various AIM companies with assets in Russia, Middle East and USA.
Representation of NYSE-listed Teledyne Technologies Incorporated on its acquisition of UK-based, AIM-listed Intelek PLC worth approximately £30 million.
Representation of various mineral and energy companies with assets based in CIS and Latin America, advising on acquisition of assets and associated rights, private and institutional fundraising (US$10 to US$50) and listing on the AIM market.
Representation of a Middle Eastern client on the purchases of hotel businesses (including freehold and leasehold properties) for consideration in excess of £85m.
Representation of a U.S. bank in connection with security trustee arrangements relating to the issuance of up to US$50 of secured loan notes.
Representation of a property investment company with its term loan financing.
Representation of a client on setting up a multimillion dollar private equity fund in the Middle East.
Representation of large corporations on setting up of their operations in the financial centres and free-zones in the GCC region.
Representation of a client in the first ever court case in the Qatar Finance Centre in winding-up of a joint-venture.
Representation of a U.S. major on its planning and implementation of post acquisition integration involving 11 jurisdictions.
Representation of a large medical devices corporation on the post –acquisition integration involving 13 jurisdictions in Europe, North America, Middle East and Asia.
Representation of U.S. multinationals on data transfers from EEA countries and compliance with EU data privacy requirements.
Representation of an EU-based structured investment company on passporting its regulatory authorizations into the UK, its UK operations, and ongoing compliance matters.
Representation of an EU-based insurance broker on passporting its regulatory authorizations into the UK and setting up branch operations.
Representation of an investment bank on an abortive cross-border U.S. $50 million IPO fundraising and admission to AIM of a Middle Eastern produce distribution company.
Representation of Evergreen Securities Plc (formerly Ethanol Investments PLC) on its readmission to AIM with a market capitalisation of £12.2 million following a reverse takeover.
Representation of Petrolatina Plc (formerly Taghmen Energy plc) on its admission to AIM subsequent to its private placement of US $20 million.
Representation of a UK-based Latin American resources company on its cross-border acquisition of various mining properties, pre-IPO private placements totaling approximately U.S. $15 million, its abortive admission to AIM, secured debt facilities totaling US $45 million, and a potential reverse into an AIM-listed company.
Representation of a corporate finance house in its capacity as a Rule 3 adviser on a competing hostile takeover of an AIM-listed company.
Representation of Escalon Medical Corp. (listed on NASDAQ Small Cap Market) on its takeover of Drew Scientific Group PLC (listed on Official List).
Representation of a UAE-based company on its purchase of a UK manufacturing plant from a company in administration.
Representation of Jubilee Investment Trust Plc (net asset value of more than £30m) on its listing on Official List and its subsequent takeover bid for New Opportunities Investment Trust Plc.
Representation of a BVI company on a convertible loan note issue.